Martin Christopher Nathan has filed 3 insider transactions across 3 companies since November 2025.
Most recent transaction: a grant/award of 47250 shares of ACHIEVE LIFE SCIENCES, INC. ($ACHV) on May 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Martin Christopher Nathan | Not found | A | Stock Option (right to buy) | 47250 | $0.00 | 47,250.0000 | 53,233,988 | 9999.99% | 0.09% |
| Dec. 11, 2025 | Oruka Therapeutics, Inc. | $ORKA | Martin Christopher Nathan | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 42,095,951 | 9999.99% | 0.08% |
| Nov. 19, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Martin Christopher Nathan | Not found | A | Stock Options (Right to buy) | 45150 | $0.00 | 45,150.0000 | 105,492,779 | 9999.99% | 0.04% |